This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
University of Edinburgh
Drug Names(s): UE-2343
Description: UE2343 is a potent oral inhibitor of 11-beta-HSD1.
Deal Structure: UE2343 is being developed by the University of Edinburgh and Argenta, a drug discovery arm of Galapagos NV (acquired in February 2010).
Partners: Galapagos NV
Additional information available to subscribers only: